MAXCYTE, INC.
MXCT · XNASCIK 1287098fmd_1JXT3QEF7RSBE7QC03PEPF7QEMServices · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Rental revenue | 8 | 11 | 12 | 16 | 22 | 16 | 12 |
| Total revenues | 22 | 26 | 34 | 44 | 41 | 39 | 33 |
| Cost of revenue | 2 | 3 | 4 | 5 | 5 | 7 | 6 |
| Gross profit | 19 | 23 | 30 | 39 | 37 | 32 | 27 |
| Research and development | 18 | 18 | 15 | 20 | 24 | 22 | 21 |
| Selling, general and administrative | 13 | 16 | 32 | 44 | 57 | 56 | 47 |
| Total operating expenses | 32 | 34 | 48 | 67 | 85 | 83 | 79 |
| Operating income | (12) | (11) | (18) | (27) | (48) | (51) | (52) |
| Interest expense | 0 | 0 | 0 | – | – | – | – |
| Interest and investment income | 0 | 0 | 0 | 4 | 10 | 10 | 7 |
| Other non-operating income (expense) | (0) | (1) | (1) | 4 | 10 | 10 | 7 |
| Income before taxes | – | – | – | – | (38) | (41) | (45) |
| Income tax expense | 0 | 0 | 0 | – | – | – | – |
| Net income | (13) | (12) | (19) | (24) | (38) | (41) | (45) |